AbbVie Expands Immunology Portfolio in Canada as Health Canada approves SKYRIZI® for the Treatment of Adults with Active Psoriatic Arthritis Pharmaceutical Investing
Potent Ventures Secures Partnership with Influencer Michelle Cehn in Advance of Launch of The Gummy Project Biotech Investing
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm Pharmaceutical Investing
RINVOQ® Receives FDA Approval for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis Pharmaceutical Investing
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm Pharmaceutical Investing
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm Pharmaceutical Investing
Now Available Over the Counter, LASTACAFT® Provides Eye Allergy Itch Relief in Minutes that Lasts Through 16 Hours Pharmaceutical Investing
AbbVie and Scripps Research Announce Collaboration to Develop Antiviral Treatments for COVID-19 Pharmaceutical Investing
